Specialty Pharmacy

A new report by the Berkeley Research Group provides numbers on Medicare Part B spending by 340B entities, especially for oncology drugs.

The FDA has approved sugammadex (Bridion) to reverse the effects of neuromuscular blockade created by rocuronium bromide and vercuronium bromide.

Panel suggests different regimens for different hepatitis C patient groups.

Pharmacists continue to rank among the most honest and ethical professionals in America, according to Gallup's latest poll on the topic.

Pharmacists in Minnesota are fighting for the rights to take breaks and refuse to work more than 12 hours in a row.

New treatments for HIV infection are desperately needed.

There may be several different disorders within Crohn's disease and ulcerative colitis.

Latest developments in oncology drug research.

Hope on the horizon for patients with liver damage.

Researchers seek a better understanding of the mechanism behind hepatocellular carcinoma.

Four specific gut bacteria protect babies from developing asthma.

Revenue not expected to maintain pace of current immunology treatments.

Catch up with the most read articles of the week on Specialty Pharmacy Times.

Democrats and Republicans agreeing on something having to do with the Affordable Care Act is unusual, but there is one aspect of the health care law that both parties feel the same about: the excise, or Cadillac, tax.

New research may allow for HIV to be attacked at its core.

Researchers evaluate link between hemoglobin and morbidity in patients who undergo major gastrointestinal surgery.

Diabetes is a known risk factor for cognitive decline and dementia.

Statins show promise to reduce liver disease incidence in coinfected patients.

As population health management becomes increasingly critical, health-system pharmacists should reacquaint themselves with the factors driving patient outcomes.

CVS Health is looking into a claim that one of its pharmacies in Texas dispensed the wrong medication to a woman more than once.

Aggressive new approaches considered to curb financial hit from prescription drugs.

Severity and type of symptoms varies among cancer patients in different age groups.

Continued steroid use associated with worse anxiety, sleep, and fatigue.

Average MS onset for patients who spent time in the sun every day is nearly two years later than patients who did not spend daily time in the sun.

REMS deemed unnecessary to ensure drug benefits outweigh risks.

Traveling a longer distance to a medical center was not associated with spending more time on a waiting list.

C-reactive protein is useful in the diagnosis and treatment of some acute or chronic inflammatory conditions.

Health-system pharmacists will inevitably face growing ethical challenges as their roles in patient care continue to evolve.

Out-of-pocket costs to remain a significant hurdle for patients even after closing of coverage gap.